BCC COVID Infusion Center - Provider Referrals
The Baltimore Convention Center Field Hospital (BCCFH) is operating an outpatient infusion center to administer two monoclonal antibody therapies, authorized by the Federal Drug Administration (FDA) under an Emergency Use Authorization (EUA).
Monoclonal Antibody Therapies at BCCFH
Both treatments have the same FDA Emergency Use Authorization (EUA) criteria and have been demonstrated to reduce COVID-19 hospitalization or emergency room visits when administered within 10 days of symptom onset.
The monoclonal antibody therapies offered at the BCC COVID Infusion Center include:
- A combination of bamlanivimab and etesevimab (manufactured by Eli Lilly) - Read the Provider Fact Sheet
- A combination of casirivimab and imdevimab (also known as REGN-COV, manufactured by Regeneron) - Read the Provider Fact Sheet
Hours: The COVID Infusion Center is open Tuesday, Thursday and Saturday, 2 pm – 5 pm.
For Referring Providers
NEW REFERRAL PROCESS: To refer a patient for treatment to the Baltimore Convention Center COVID Infusion Center, outpatient providers should click on the button below:
The Baltimore Convention Center Infusion Suite team will review the referral form upon receipt and contact the patient to coordinate services as soon as possible. Please alert your patient to expect a call from us.
Please note all of the following:
- We provide medications that match prevalence and susceptibility data of COVID variants in our area. Beyond that, which treatment to administer is chosen based on availability and logistics.
- Our prioritization methodology for patients is based on duration of symptom onset. At this point there is no further risk stratification based on clinical or other characteristics.
- There is always the possibility that a patient's clinical condition may change during the time between referral and arrival to the infusion center, to the point where mAb therapy may no longer be indicated for the patient. If a patient has clinically declined by the time they arrive at the infusion center, we will refer them to a higher level of care, if needed, without administering mAb.
We strongly prefer for patients to be seen and referred by their primary care or other provider. However, if you are newly COVID-positive and do not have a provider, you may contact the BCCFH to speak with a doctor who can explain monoclonal antibody therapy and figure out if it is right for you.
Please either complete a self-referral form at umms.org/BCCInfusion or call the Convention Center Infusion Center at 410-649-6122 between the hours of 8 am – 5pm, Monday through Friday to reach the clinical team.
For more information about receiving treatment at BCCFH, please visit BCC COVID Infusion Center Patient Information.
Jointly operated by: